|
He learned this week that his cancer, chronic
myeloid leukemia, is in remission.
The 33-year-old center announced that recent tests found no
leukemia cells.
Boyle had been diagnosed Sept. 19, 2017, but he returned to the
action six weeks later, playing through the rest of last season
while undergoing cancer treatments.
"A test (BCR-ABL1) looks for the leukemia cells in your blood,
and when I was first diagnosed, it was at 75 percent," Boyle
told NHL.com on Wednesday. "At the end of last season, it was at
.08 percent, and in July I was .04 percent. The results showed
all zeros on Monday. It's full molecular remission, and I feel
really good. It was kind of the way the progression was
happening the last few tests. ...
"The game plan has been working well, and now I'm just going to
continue with it. It was good news, but it doesn't change a
whole lot for me, and I'll continue taking the medicine
(monthly)."
He also will still go for regular checkups.
Last season, Boyle finished with 13 goals and 10 assists in 69
games. he was awarded the NHL's Masterton Trophy, given to the
player who best represents the qualities of perseverance,
sportsmanship and dedication.
In 12 NHL seasons, Boyle has 109 goals and 87 assists in 699
games. A first-round pick of the Kings in 2003, he played parts
of two seasons for Los Angeles before playing for the New York
Rangers, Tampa Bay Lightning and Toronto Maple Leafs. He is in
his second season with the Devils.
--Field Level Media
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
 |
|
